Differences in the Role of HDACs 4 and 5 in the Modulation of Processes Regulating MAFbx and MuRF1 Expression During Muscle Unloading
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Unloading leads to skeletal muscle atrophy via the upregulation of MuRF-1 and MAFbx E3-ligases expression. Reportedly, histone deacetylases (HDACs) 4 and 5 may regulate the expression of MuRF1 and MAFbx. To examine the HDAC-dependent mechanisms involved in the control of E3-ubiquitin ligases expression at the early stages of muscle unloading we used HDACs 4 and 5 inhibitor LMK-235 and HDAC 4 inhibitor Tasqinimod (Tq). Male Wistar rats were divided into four groups (eight rats per group): nontreated control (C), three days of unloading/hindlimb suspension (HS) and three days HS with HDACs inhibitor LMK-235 (HSLMK) or Tq (HSTq). Treatment with LMK-235 diminished unloading-induced of MAFbx, myogenin (MYOG), ubiquitin and calpain-1 mRNA expression ( < 0.05). Tq administration had no effect on the expression of E3-ligases. The mRNA expression of MuRF1 and MAFbx was significantly increased in both HS and HSTq groups (1.5 and 4.0 folds, respectively; < 0.05) when compared with the C group. It is concluded that during three days of muscle unloading: (1) the HDACs 4 and 5 participate in the regulation of MAFbx expression as well as the expression of MYOG, ubiquitin and calpain-1; (2) the inhibition of HDAC 4 has no effect on MAFbx expression. Therefore, HDAC 5 is perhaps more important for the regulation of MAFbx expression than HDAC 4.
Role of PI3 Kinases in Cell Signaling and Soleus Muscle Atrophy During Three Days of Unloading.
Zaripova K, Belova S, Kostrominova T, Shenkman B, Nemirovskaya T Int J Mol Sci. 2025; 26(1.
PMID: 39796270 PMC: 11720661. DOI: 10.3390/ijms26010414.
Epigenetics of Skeletal Muscle Atrophy.
Du J, Wu Q, Bae E Int J Mol Sci. 2024; 25(15).
PMID: 39125931 PMC: 11312722. DOI: 10.3390/ijms25158362.
Dai D, Wu D, Ni R, Li P, Tian Z, Shui Y Front Mol Biosci. 2023; 10:1162409.
PMID: 37503539 PMC: 10368982. DOI: 10.3389/fmolb.2023.1162409.
Gu Y, Lin Y, Li M, Zong C, Sun H, Shen Y Ann Transl Med. 2022; 10(9):516.
PMID: 35928746 PMC: 9347038. DOI: 10.21037/atm-21-6512.
Paramonova I, Vilchinskaya N, Shenkman B Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832949 PMC: 8617770. DOI: 10.3390/ph14111167.